1. [Hemodynamic efficacy of modified gelatin in patients with acute blood loss and sepsis].
- Author
-
Kochergina VV, Vlasenko AV, Moroz VV, Evdokimov EA, Iakovlev VN, and Alekseev VG
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Female, Hemorrhage etiology, Hemorrhage physiopathology, Humans, Hypovolemia etiology, Hypovolemia physiopathology, Intensive Care Units, Male, Middle Aged, Sepsis etiology, Sepsis physiopathology, Treatment Outcome, Young Adult, Gelatin administration & dosage, Hemodynamics physiology, Hemorrhage therapy, Hypovolemia prevention & control, Plasma Substitutes administration & dosage, Sepsis therapy, Succinates administration & dosage
- Abstract
The paper presents the results of a clinical trial using the new modified gelatin-based drug hemofusin to correct dyshidria in patients with blood loss and sepsis. Based on the findings, the authors provide evidence for the high clinical efficacy of this drug and the expediency of its incorporation into a complex of infusion therapy in this patient contingent.
- Published
- 2010